Cloning, expression and characterization of the gene encoding the enolase from Fusobacterium nucleatum
- Authors: Yakarsonmez S.1, Erdemir A.1, Cooper P.R.2, Milward M.R.2, Topuzogullari M.1, Sariyer E.1, Nural B.3, Mutlu O.4, Cayir E.1, Turgut-Balik D.1
-
Affiliations:
- Department of Bioengineering
- Department of Periodontology
- Department of Biotechnology and Biosafety
- Department of Biology, Goztepe Campus
- Issue: Vol 52, No 1 (2016)
- Pages: 23-30
- Section: Article
- URL: https://journals.rcsi.science/0003-6838/article/view/151835
- DOI: https://doi.org/10.1134/S0003683816010142
- ID: 151835
Cite item
Abstract
The gene encoding enolase from Fusobacterium nucleatum (FnENO) was cloned and analyzed for the first time. The gene comprises of 1302 nucleotide base pairs and encodes 433 amino acids. The gene sequence alignment demonstrated the presence of several distinct insertions and deletions, compared with the human enzyme. The gene for recombinant FnENO was inserted into the pLATE 31 vector system and expressed in E. coli BL21(DE3) cells as a soluble protein. The protein was purified by affinity chromatography using a Ni-NTA agarose matrix and shown on SDS-PAGE to be a 46 kDa protein. The molecular weight of the octameric form of the purified recombinant protein was determined as being 375 kDa by size exclusion chromatography. Optimal enzyme activity was observed at pH 8.5 and the enzyme remained stable at a range of different temperatures from 30 to 60°C. Using 2-phosphoglyceric acid as substrate for the purified enzyme, KM, kcat and kcat/KM were determined as 0.48 mM, 20.4 s–1 and 4.22 × 104 M–1s–1, respectively. Potential drug binding sites of FnENO were detected using homology modeling. These data could facilitate the design of new inhibitors of F. nucleatum which has already been shown to be resistant to several known antibiotics.
About the authors
S. Yakarsonmez
Department of Bioengineering
Email: dilekbalik@gmail.com
Turkey, Davutpasa Campus, Esenler, Istanbul, 34210
A. Erdemir
Department of Bioengineering
Email: dilekbalik@gmail.com
Turkey, Davutpasa Campus, Esenler, Istanbul, 34210
P. R. Cooper
Department of Periodontology
Email: dilekbalik@gmail.com
United Kingdom, Birmingham, B4 6NN
M. R. Milward
Department of Periodontology
Email: dilekbalik@gmail.com
United Kingdom, Birmingham, B4 6NN
M. Topuzogullari
Department of Bioengineering
Email: dilekbalik@gmail.com
Turkey, Davutpasa Campus, Esenler, Istanbul, 34210
E. Sariyer
Department of Bioengineering
Email: dilekbalik@gmail.com
Turkey, Davutpasa Campus, Esenler, Istanbul, 34210
B. Nural
Department of Biotechnology and Biosafety
Email: dilekbalik@gmail.com
Turkey, Meselik, Eskisehir
O. Mutlu
Department of Biology, Goztepe Campus
Email: dilekbalik@gmail.com
Turkey, Goztepe, Istanbul, 34722
E. Cayir
Department of Bioengineering
Email: dilekbalik@gmail.com
Turkey, Davutpasa Campus, Esenler, Istanbul, 34210
D. Turgut-Balik
Department of Bioengineering
Author for correspondence.
Email: dilekbalik@gmail.com
Turkey, Davutpasa Campus, Esenler, Istanbul, 34210
Supplementary files
